Loading...
UG logo

United-Guardian, Inc.NasdaqGM:UG Stock Report

Market Cap US$31.6m
Share Price
US$6.87
US$10.6
35.2% undervalued intrinsic discount
1Y-16.7%
7D-7.5%
Portfolio Value
​
View

United-Guardian, Inc.

NasdaqGM:UG Stock Report

Market Cap: US$31.6m

United-Guardian (UG) Stock Overview

Develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. More details

UG fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Rewards

Trading at 35.2% below our estimate of its fair value

Risk Analysis

Earnings have declined by 11.4% per year over past 5 years

Dividend of 7.28% is not well covered by earnings or free cash flows

Does not have a meaningful market cap ($32M)


UG Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

United-Guardian, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for United-Guardian
Historical stock prices
Current Share PriceUS$6.87
52 Week HighUS$9.88
52 Week LowUS$5.58
Beta0.97
1 Month Change4.97%
3 Month Change2.69%
1 Year Change-16.73%
3 Year Change-29.17%
5 Year Change-55.45%
Change since IPO31.34%

Recent News & Updates

Analysis Article • Feb 03

What United-Guardian, Inc.'s (NASDAQ:UG) 25% Share Price Gain Is Not Telling You

United-Guardian, Inc. ( NASDAQ:UG ) shares have had a really impressive month, gaining 25% after a shaky period...
Analysis Article • Feb 01

United-Guardian (NASDAQ:UG) Has Announced A Dividend Of $0.25

United-Guardian, Inc. ( NASDAQ:UG ) has announced that it will pay a dividend of $0.25 per share on the 17th of...
Analysis Article • Nov 08

United-Guardian (NASDAQ:UG) Will Be Looking To Turn Around Its Returns

What financial metrics can indicate to us that a company is maturing or even in decline? A business that's potentially...
Analysis Article • Jul 16

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Recent updates

Analysis Article • Feb 03

What United-Guardian, Inc.'s (NASDAQ:UG) 25% Share Price Gain Is Not Telling You

United-Guardian, Inc. ( NASDAQ:UG ) shares have had a really impressive month, gaining 25% after a shaky period...
Analysis Article • Feb 01

United-Guardian (NASDAQ:UG) Has Announced A Dividend Of $0.25

United-Guardian, Inc. ( NASDAQ:UG ) has announced that it will pay a dividend of $0.25 per share on the 17th of...
Analysis Article • Nov 08

United-Guardian (NASDAQ:UG) Will Be Looking To Turn Around Its Returns

What financial metrics can indicate to us that a company is maturing or even in decline? A business that's potentially...
Analysis Article • Jul 16

Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Analysis Article • Apr 09

United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...
Analysis Article • Nov 14

United-Guardian, Inc. (NASDAQ:UG) Not Doing Enough For Some Investors As Its Shares Slump 29%

United-Guardian, Inc. ( NASDAQ:UG ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article • Nov 09

These Return Metrics Don't Make United-Guardian (NASDAQ:UG) Look Too Strong

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? Businesses...
Analysis Article • Sep 08

Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%

United-Guardian, Inc. ( NASDAQ:UG ) shares have continued their recent momentum with a 26% gain in the last month...
Analysis Article • Jul 22

United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's

The board of United-Guardian, Inc. ( NASDAQ:UG ) has announced that the dividend on 31st of July will be increased to...
Analysis Article • Jul 15

Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price

There wouldn't be many who think United-Guardian, Inc.'s ( NASDAQ:UG ) price-to-earnings (or "P/E") ratio of 18.2x is...
Analysis Article • May 14

United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively

When researching a stock for investment, what can tell us that the company is in decline? Businesses in decline often...
Seeking Alpha • Feb 20

United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside

Summary Temporary setbacks have given investors a great entry point before recovery in the company's segments. New markets and potential dividend increases could be a boon to the share price over the next few years. United-Guardian's balance sheet is in spectacular order, and the businesses operate in resilient markets. Read the full article on Seeking Alpha
Analysis Article • Feb 04

Returns On Capital Signal Difficult Times Ahead For United-Guardian (NASDAQ:UG)

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...
Analysis Article • Dec 29

United-Guardian, Inc.'s (NASDAQ:UG) Share Price Is Matching Sentiment Around Its Earnings

With a price-to-earnings (or "P/E") ratio of 12.8x United-Guardian, Inc. ( NASDAQ:UG ) may be sending bullish signals...
Analysis Article • Nov 07

Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Key Insights Using the 2 Stage Free Cash Flow to Equity, United-Guardian fair value estimate is US$6.94 With US$7.40...
Analysis Article • Jul 18

Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

Key Insights The projected fair value for United-Guardian is US$9.07 based on 2 Stage Free Cash Flow to Equity...
Analysis Article • Mar 07

United-Guardian (NASDAQ:UG) Is Achieving High Returns On Its Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article • Nov 11

Why We Like The Returns At United-Guardian (NASDAQ:UG)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Oct 12

Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

How far off is United-Guardian, Inc. ( NASDAQ:UG ) from its intrinsic value? Using the most recent financial data...
Seeking Alpha • Aug 15

Buying Back Into United-Guardian, Inc.

Since I took my chips off the table a few months back, the shares have lost over 1/3 of their value. This has put the company back on my radar. The company is less profitable, to be sure, but the dividend is reasonably well-supported, and the yield is high. This gives investors time to wait for a turnaround. We're told to "buy when others are fearfully selling." This is easier said than done, and I think United-Guardian is an example of this phenomenon. If you've got a vague inkling that the only reason I write on this platform is to brag publicly, get ready for that inkling to be massively reinforced, because today will see some industrial-grade bragging on my part. I'll try (unsuccessfully) to ignore this annoying little voice in my head yammering something about "pride goeth the fall" or whatever, so I can focus on writing about the latest win. As I pointed out in my latest piece about United-Guardian, Inc. (UG). I had outperformed the S&P 500 slightly over the previous four years, but it was time to take chips off the table. I did that this past April, and since then the shares are down about 36%. So, to drive the point home, in 2018 I was bullish on this stock and rode it to a great return. This past April I sold shares, and they've lost over ⅓ of their value since. I want to revisit this name primarily to brag, obviously, but I think there are some other reasons to revisit the name. Specifically, the company has posted financial results since I last looked at the company, and those deserve commentary. Additionally, a stock trading at $15.50 is much less risky an investment than the same stock trading at $24.50, so it may be worth buying back in at this point. I'm self-aware enough to realise that my writing can be tiresome to many. I spell words properly, and that may bother some of my American audience, with their, uh, "singular" approach to the English language. Worse, I can be a tiresome braggart, as I've already demonstrated above. This may offer some clues about the current state of my social life. Anyway, whatever the reason, I fully understand that you may not want to douse yourself in undiluted "Doyle mojo." For that reason, I offer up a "thesis statement" paragraph in each of my articles. This gives you the highlights of my argument without needing to wade through the swamp that is a full-blown article. You're welcome. Here goes. I'll be buying back into this company this morning because the shares are now sufficiently cheap again. I'm doing this in spite of the recent drop in profitability. I think the dividend is reasonably well covered, and I think the high dividend yield will be supportive of price, suggesting very limited downside from here. That said, even if the shares drop in price from the current level, the dividend will compensate for any losses over time in my view. I like investments where time is your friend, and that is certainly the case here. There you have it. If you continue to read from this point, any resulting nausea that my writing produces is on you. Company Background & Risks In case you're unfamiliar with United-Guardian, I'll do my best to enlighten you. The company operates in four distinct product categories: cosmetic ingredients, pharmaceuticals, medical products, and specialty industrial products, and each of these is marketed slightly differently. In all four categories, the company is focused on R&D activities, as evidenced by the fact that it's been granted 30 patents since its founding in 1942. The R&D efforts in the cosmetic ingredients space have been directed toward formulating "natural" products that are used as components of various cosmetic products that are then included in the formulations produced by marketing partners. The company sells its cosmetic ingredients through 5 marketing partners, the largest of which is Ashland Specialty Ingredients. These partnerships are ideal because partners have much deeper market penetration and reach than the company could achieve. The "cosmetic ingredients" category is the company's largest (~49% of sales) and fastest growing, and it is the group of products that I'm most excited about. In particular, I have high hopes for the Lubrajel suite of products. I think the macro background is quite favourable, because the demand for "natural" products is expected to grow somewhere between a healthy 5.3% and an eye-watering 6.6% pace over the next 8 years. There are two risks that I've been able to identify here. The first of these is the currency. Although fully 80% of sales take place in the United States, the stronger U.S. dollar will inevitably impact sales going forward. The next risk involves the company's ability to obtain raw materials. They have consistently been able to acquire what they needed, even during the height of the pandemic, some materials are now more expensive, and there are now longer lead times for some of them. The rising dollar and increased costs may obviously impact the company's gross profit margin on certain products. Financial Snapshot Relative to the first six months of 2021, the financial performance during the most recent period has obviously been mixed. Revenue during the first six months of the year saw sales up by about 6% compared to 2021, but net income has collapsed, down by ~$981 thousand, or 39%. The reason for this relates to increased costs of sales, operating expenses, and R&D expenses, each up by 19%, 20.3%, and 11.74% respectively. Additionally, the company took an $854 thousand dollar loss on marketable securities. The capital structure also deteriorated fairly significantly relative to the same period in 2021, with total liabilities up by ~15%, and cash down by about 21.5%. While I like making comparisons from one period to the next, it's sometimes troubling because one or both periods may not be representative. For instance, you may remember that there was a global pandemic in 2020-2021 that turned off global economic activity, and thus any comparisons to that period may be fraught with bias. For that reason, I also want to draw a comparison between the most recent period and the first six months of 2019, as the latter period is free of the pernicious effects of the pandemic. When compared to 2019, similar themes emerge. Revenue was higher and net income was lower in 2022, and the capital structure in 2022 was also much weaker. Given the above, I think it's reasonable to suggest that a part of the stock price weakness relates to the drop-off in income. One thing that buoys the stock price, though, is the dividend, and so I want to write briefly about it. If the dividend is reasonably secure, and the valuation is low enough, I'd be very happy to buy back in. The company generated $1.164 million in cash from operations during the first six months of 2022, compared to $2.6 million during the same period in 2021. The reason for the drop obviously relates to a drop in net income, but there are two other factors worth noting. First, the company spent $317.4 thousand on new inventories and spent $231.4 thousand in prepaid taxes. I think these will either add to future cash inflows, or at least reduce future outflows. During the same period, the company spent $1,699.392 on dividends, or about $535,000 more than it generated in cash from operations. It's also relevant that the company has $355 thousand in cash and approximately $6.4 million in marketable securities. Finally, although I moaned about "deterioration" above, I think it's worth noting that "cash and marketable securities" is still over 3x greater than "total liabilities." Thus, I'm reasonably confident that the dividend can be maintained here, and for that reason, I'd be happy to buy back in at the right price. United-Guardian Financials (United-Guardian Investor Relations) The Stock If you read my stuff regularly you know what time it is. It's the time where I turn into a bit of a financial "hall monitor", where I remind everyone that a company is distinct from its stock. The company buys inputs and sells them (ideally) at a profit. In the final analysis, that's all any company is. The stock, on the other hand, is a piece of paper that gets traded around in a public market and is influenced by a great many factors, many of which are only peripherally related to the underlying business. For instance, the stock price is certainly impacted by the company's recent financial performance. It's also impacted by the crowd's ever-changing views about the company's future financial performance. It's also potentially impacted by the changing moods of an influential analyst. Finally, the stock is influenced by the crowd's ever-changing perspectives on the relative merits of "stocks" as an asset class. For these reasons, the stock is a much more volatile thing than the underlying business. While this is tiresome, it is potentially profitable. If we can spot the discrepancies between the crowd's take on a given business, and the assumptions embedded in the price, we can earn a profit. Although I'm very, very sorry to circle back on this point, I bought when the market for these shares became excessively pessimistic years ago, and sold when the market became excessively optimistic. That was a lie. I wasn't at all sorry about reminding you of my success with this one. I really, really hope you forgive me. Anyway, I've found that cheaper stocks offer a higher risk-adjusted return, so I like to buy shares when I consider them to be cheap and eschew them when they get expensive. If you're one of my regular reader-victims you know that I measure the cheapness (or not) of a stock in a few ways, ranging from the simple to the more complex. On the simple side, I look at the ratio of price to some measure of economic value like sales, earnings, free cash flow, and the like. Ideally, I want to see a stock trading at a discount to both its own history and the overall market. In my previous missive, I took profits here because the price to free cash reached 22.5 times. The shares are now about 25% cheaper on that basis per the following: UG data by YCharts While the shares are relatively cheaper, investors are (unsurprisingly) being compensated with a much higher dividend yield, per the following: UG data by YCharts
Analysis Article • May 15

United-Guardian (NASDAQ:UG) Will Pay A Smaller Dividend Than Last Year

United-Guardian, Inc. ( NASDAQ:UG ) is reducing its dividend to US$0.37 on the 1st of Junewhich is 23% less than last...
Seeking Alpha • Apr 11

United-Guardian: Pristine Balance Sheet, Nice Dividend, But Fully Valued

We advised the subscribers to our research to buy dividend-paying United-Guardian at $14 per share in July 2020 for their income portfolio. United-Guardian has paid dividends since 1999, and we project that it will continue to pay dividends in the foreseeable future. From a valuation standpoint, UG stock, at the current price of $23, is fully valued. As a result of the ongoing strategic alternatives review, a sale is likely, but we believe that a buyout offer with a significant premium is not likely. There are much cheaper undiscovered names with pristine balance sheets and stronger upside potential.
Analysis Article • Feb 01

Estimating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)

How far off is United-Guardian, Inc. ( NASDAQ:UG ) from its intrinsic value? Using the most recent financial data...
Analysis Article • May 12

We Think Shareholders May Want To Consider A Review Of United-Guardian, Inc.'s (NASDAQ:UG) CEO Compensation Package

United-Guardian, Inc. ( NASDAQ:UG ) has not performed well recently and CEO Ken Globus will probably need to up their...
Analysis Article • Mar 15

Do Investors Have Good Reason To Be Wary Of United-Guardian, Inc.'s (NASDAQ:UG) 5.1% Dividend Yield?

Is United-Guardian, Inc. ( NASDAQ:UG ) a good dividend stock? How can we tell? Dividend paying companies with growing...
Analysis Article • Feb 23

Should We Be Excited About The Trends Of Returns At United-Guardian (NASDAQ:UG)?

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Analysis Article • Feb 02

Calculating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)

Today we will run through one way of estimating the intrinsic value of United-Guardian, Inc. ( NASDAQ:UG ) by...
Analysis Article • Jan 13

United-Guardian's (NASDAQ:UG) Shareholders Are Down 11% On Their Investment Over The Past Five Years.

Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...
Analysis Article • Dec 22

Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

United-Guardian (NASDAQ:UG) has had a rough three months with its share price down 4.1%. It is possible that the...
Analysis Article • Dec 04

Our View On United-Guardian's (NASDAQ:UG) CEO Pay

This article will reflect on the compensation paid to Ken Globus who has served as CEO of United-Guardian, Inc...

Shareholder Returns

UGUS Personal ProductsUS Market
7D-7.5%3.6%2.2%
1Y-16.7%-14.0%31.1%

Return vs Industry: UG underperformed the US Personal Products industry which returned -14% over the past year.

Return vs Market: UG underperformed the US Market which returned 31.1% over the past year.

Price Volatility

Is UG's price volatile compared to industry and market?
UG volatility
UG Average Weekly Movement4.9%
Personal Products Industry Average Movement9.0%
Market Average Movement7.3%
10% most volatile stocks in US Market16.1%
10% least volatile stocks in US Market3.2%

Stable Share Price: UG has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: UG's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194224n/au-g.com

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO.

United-Guardian, Inc. Fundamentals Summary

How do United-Guardian's earnings and revenue compare to its market cap?
UG fundamental statistics
Market capUS$31.56m
Earnings (TTM)US$2.36m
Revenue (TTM)US$10.94m
13.4x
P/E Ratio
2.9x
P/S Ratio

Is UG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UG income statement (TTM)
RevenueUS$10.94m
Cost of RevenueUS$5.73m
Gross ProfitUS$5.21m
Other ExpensesUS$2.84m
EarningsUS$2.36m

Last Reported Earnings

Mar 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.51
Gross Margin47.62%
Net Profit Margin21.61%
Debt/Equity Ratio0%

How did UG perform over the long term?

See historical performance and comparison

Dividends

7.3%
Current Dividend Yield
97%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/11 06:16
End of Day Share Price 2026/05/08 00:00
Earnings2026/03/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

United-Guardian, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.